Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG + MMC in High-Risk NMIBC
NCT06462001Phase 3Active, not recruiting
- Sponsor
- Nottingham University Hospitals
- Start
- Dec 2020
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 3 trial of mitomycin c in non-muscle-invasive bladder cancer (NMIBC), sponsored by Nottingham University Hospitals. Started Dec 2020; status: active, not recruiting.
02
Drugs
mitomycin c
03
Conditions
non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT06462001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06462001.